Top Vaccine Discovery and Development Solution Companies in Europe
Pharma Tech Outlook
CanVirex: Cancer Vaccination to Activate Anti-Tumor Immune Response
line

Top 10 Vaccine Discovery and Development Solution Companies in Europe - 2020

line

Since its discovery, vaccine discovery and development continue to be the integral component of therapeutics in combating the plethora of infectious diseases. Over the years, rapid advances in proteomics, genomics, genetic therapy, and technologies have added new dimensions to the efficiency of vaccines. Take, for instance, the multiple antigen-presenting systems (MAPS) that have emerged as one of the innovative modular approaches to vaccine production. MAPS combine biotin and a fusion of proteins such as rhizavidin to form a tight molecule that enables pharmacists to create cost-effective complex molecular structures that are more potent than the sum of its parts and trigger a more robust immune response. Furthermore, to stimulate accurate immune responses, researchers are now creating human tissue construct using human blood cells (HBC), plasma, immune cells, and other components that make it possible to model age-specific vaccine formulations.

Keeping in mind such drastic transitions, we have compiled this issue of Pharma Tech Outlook in order to assist organisations in the task of finding accomplished solution providers to help them navigate the vaccine discovery and development realm. In this edition, we have listed the top 10 vaccine discovery and development solution providers in Europe - 2020 to highlight the enterprises that can escalate the chances of your growth. Equipped with innovative technological capabilities, these enlisted solution providers are transforming the vaccine discovery and development paradigm at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts, CIOs, and CXOs in the pharmaceutical sector on the latest industry trends, best practices, recent innovations, and highlights their expertise. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organisation need to foster an environment driven by robust and efficient technology.

We present to you Pharma Tech Outlook’s “Top 10 Vaccine Discovery and Development Solution Providers in Europe - 2020”

    Top Vaccine Discovery and Development Solution Companies in Europe

    CanVirex offers an innovative and highly promising measles virus vector-based platform for cancer immunotherapy and infectious diseases. The company’s oncolytic viruses are genetically engineered to encode immunomodulatory payloads (transgenes)that activate the patient’s immune system specifically. The measles vector is highly flexible and can be considered a versatile platform to deliver all kinds of immune modulating transgenes. After application, these transgenes are produced by the infected tumour cells and trigger powerful T cell responses that can be capable of tumour clearance and prevention of tumour relapse. CanVirex’s technology of vector engineering can also be used for vaccination against infectious diseases. The company’s measles-based COVID-19 vaccine encodes a SARS-CoV-2 antigen that has been shown to induce significant cellular and humoral immune responses, making it an ideal candidate for the fight against the virus ... read full profile
    Founded in 2005, SYNENTEC consists of an interdisciplinary team of engineers, software developers, and biologists. The company offers automated high-throughput cell culture microscopes such as the CELLAVISTA® and the NYONE® as well as fast and easy to use YT-image analysis software to provide excellent application support, quick technical service and customised product demonstrations to help answer individual cell culture queries at every step of vaccine research, development, and production process ... read full profile
    CALIXAR
    CALIXAR, is a biotech company specialized in the functional and native isolation of complex therapeutic targets and antigens. The company develop and implement chemistry and biochemistry tools to isolate in solution - with the highest purity levels - full-length membrane proteins, while keeping their structural and functional integrity
    Cobra Biologics
    Cobra Biologics, part of the Cognate BioServices family, is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. Cobra has two GMP approved facilities in Sweden and the UK, each with specific expertise tailored to serving its customers around the world
    Genedata
    Genedata transforms data into intelligence with innovative software solutions that support large-scale, experimental processes in life science R&D. Founded in 1997, Genedata delivers enterprise solutions for data analytics that streamline R&D workflows and improve productivity. Genedata combines computational, scientific, and technical expertise with extensive biopharma R&D domain knowledge to deliver user-friendly solutions that are scalable, open, and aligned with industry processes
    Intravacc
    The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between its client's concept and late-stage clinical studies. As an established independent DVMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between clients discovery and the start of your phase I/II clinical trials in humans
    Reithera Srl
    Reithera Srl is a company devoted to develop and produce biopharmaceutical products based on gene delivery technologies for advanced therapies, in order to prevent and treat several serious or life-threatening diseases
    Takis
    Takis is a biotech dedicated to cancer research. The company's primary objective is the development of innovative therapies based on the principle that our immune system can be “instructed” to recognize the tumor and reject it as a foreign entity. For this purpose, Takis offers cutting-edge technologies and works with the idea that new cancer treatment must be based on in-depth knowledge of tumour biology and the concept of personalized cancer therapy
    Valneva
    Valneva is a specialty vaccine company focused on prevention against diseases with major unmet needs. Valneva’s portfolio includes two commercial vaccines for travelers and various vaccines in development, including unique vaccines against Lyme disease, chikungunya and COVID-19. The Company has operations in Austria, Sweden, the United Kingdom, France, Canada and the US with over 500 employees
    Zoetis
    Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on more than 65 years of experience, the company delivers quality medicines, vaccines and diagnostic products, complemented by biodevices, genetic tests and precision livestock farming. Zoetis is working every day to better understand and address the real-world challenges faced by those who raise and care for animals in ways they find truly relevant